A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-11-01
|
| Series: | CPT: Pharmacometrics & Systems Pharmacology |
| Online Access: | https://doi.org/10.1002/psp4.12465 |
| _version_ | 1828170008962793472 |
|---|---|
| author | Andrzej M. Kierzek Timothy P. Hickling Isabel Figueroa J. Cory Kalvass Marjoleen Nijsen Krithika Mohan Geertruida M. Veldman Akihiro Yamada Hiroyuki Sayama Sachiko Yokoo Abhishek Gulati Renu S. Dhanikula Jochem Gokemeijer Tarek A. Leil Craig J. Thalhauser Mario Giorgi Maciej J. Swat Vijayalakshmi Chelliah Ben G. Small Neil Benson Michael Walker Kapil Gadkar Valerie Quarmby Rong Deng Andrea Ferrante Gemma L. Dickinson Jan‐Stefan Van Der Walt Lian Zhou Xiaoying Chen Hannah M. Jones Jatin Narula Sophie Tourdot Thierry Lavé Benjamin Ribba Piet H. van derGraaf |
| author_facet | Andrzej M. Kierzek Timothy P. Hickling Isabel Figueroa J. Cory Kalvass Marjoleen Nijsen Krithika Mohan Geertruida M. Veldman Akihiro Yamada Hiroyuki Sayama Sachiko Yokoo Abhishek Gulati Renu S. Dhanikula Jochem Gokemeijer Tarek A. Leil Craig J. Thalhauser Mario Giorgi Maciej J. Swat Vijayalakshmi Chelliah Ben G. Small Neil Benson Michael Walker Kapil Gadkar Valerie Quarmby Rong Deng Andrea Ferrante Gemma L. Dickinson Jan‐Stefan Van Der Walt Lian Zhou Xiaoying Chen Hannah M. Jones Jatin Narula Sophie Tourdot Thierry Lavé Benjamin Ribba Piet H. van derGraaf |
| author_sort | Andrzej M. Kierzek |
| collection | DOAJ |
| first_indexed | 2024-04-12T03:01:31Z |
| format | Article |
| id | doaj.art-368f598c595b469b8b9deb6681ea6d5a |
| institution | Directory Open Access Journal |
| issn | 2163-8306 |
| language | English |
| last_indexed | 2024-04-12T03:01:31Z |
| publishDate | 2019-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | CPT: Pharmacometrics & Systems Pharmacology |
| spelling | doaj.art-368f598c595b469b8b9deb6681ea6d5a2022-12-22T03:50:38ZengWileyCPT: Pharmacometrics & Systems Pharmacology2163-83062019-11-0181177377610.1002/psp4.12465A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic ProteinsAndrzej M. Kierzek0Timothy P. Hickling1Isabel Figueroa2J. Cory Kalvass3Marjoleen Nijsen4Krithika Mohan5Geertruida M. Veldman6Akihiro Yamada7Hiroyuki Sayama8Sachiko Yokoo9Abhishek Gulati10Renu S. Dhanikula11Jochem Gokemeijer12Tarek A. Leil13Craig J. Thalhauser14Mario Giorgi15Maciej J. Swat16Vijayalakshmi Chelliah17Ben G. Small18Neil Benson19Michael Walker20Kapil Gadkar21Valerie Quarmby22Rong Deng23Andrea Ferrante24Gemma L. Dickinson25Jan‐Stefan Van Der Walt26Lian Zhou27Xiaoying Chen28Hannah M. Jones29Jatin Narula30Sophie Tourdot31Thierry Lavé32Benjamin Ribba33Piet H. van derGraaf34Certara QSP Certara UK Limited Sheffield UKBioMedicine Design Pfizer Andover Massachusetts USAAbbVie Inc North Chicago Illinois USAAbbVie Inc North Chicago Illinois USAAbbVie Inc North Chicago Illinois USAAbbVie Inc North Chicago Illinois USAAbbVie Inc North Chicago Illinois USAPharmacometrics JP Clinical Pharmacology and Exploratory Development Astellas Pharma Inc. Tokyo JapanAnalysis & Pharmacokinetics Research Labs Astellas Pharma Inc. Tsukuba‐shi JapanAnalysis & Pharmacokinetics Research Labs Astellas Pharma Inc. Tsukuba‐shi JapanPharmacometrics US, Clinical Pharmacology and Exploratory Development Astellas Pharma Global Development, Inc. Northbrook Illinois USABristol‐Myers Squibb Princeton New Jersey USABristol‐Myers Squibb Princeton New Jersey USABristol‐Myers Squibb Princeton New Jersey USABristol‐Myers Squibb Princeton New Jersey USACertara QSP Certara UK Limited Sheffield UKCertara QSP Certara UK Limited Sheffield UKCertara QSP Certara UK Limited Canterbury UKCertara QSP Certara UK Limited Sheffield UKCertara QSP Certara UK Limited Canterbury UKCertara QSP Certara UK Limited Sheffield UKDevelopment Sciences Genentech San Francisco California USADevelopment Sciences Genentech San Francisco California USADevelopment Sciences Genentech San Francisco California USAAME Biotechnology Discovery Research Lilly Biotechnology Center San Diego California USAEli Lilly and Company Indianapolis Indiana USAEli Lilly Research & Development Windlesham UKEli Lilly and Company Indianapolis Indiana USABioMedicine Design Pfizer Cambridge Massachusetts USABioMedicine Design Pfizer Cambridge Massachusetts USABioMedicine Design Pfizer Cambridge Massachusetts USABioMedicine Design Pfizer Andover Massachusetts USARoche Pharmaceutical Research and Early Development, Pharmaceutical Sciences Roche Innovation Center Basel Basel SwitzerlandRoche Pharmaceutical Research and Early Development, Pharmaceutical Sciences Roche Innovation Center Basel Basel SwitzerlandCertara QSP Certara UK Limited Canterbury UKhttps://doi.org/10.1002/psp4.12465 |
| spellingShingle | Andrzej M. Kierzek Timothy P. Hickling Isabel Figueroa J. Cory Kalvass Marjoleen Nijsen Krithika Mohan Geertruida M. Veldman Akihiro Yamada Hiroyuki Sayama Sachiko Yokoo Abhishek Gulati Renu S. Dhanikula Jochem Gokemeijer Tarek A. Leil Craig J. Thalhauser Mario Giorgi Maciej J. Swat Vijayalakshmi Chelliah Ben G. Small Neil Benson Michael Walker Kapil Gadkar Valerie Quarmby Rong Deng Andrea Ferrante Gemma L. Dickinson Jan‐Stefan Van Der Walt Lian Zhou Xiaoying Chen Hannah M. Jones Jatin Narula Sophie Tourdot Thierry Lavé Benjamin Ribba Piet H. van derGraaf A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins CPT: Pharmacometrics & Systems Pharmacology |
| title | A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins |
| title_full | A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins |
| title_fullStr | A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins |
| title_full_unstemmed | A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins |
| title_short | A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins |
| title_sort | quantitative systems pharmacology consortium approach to managing immunogenicity of therapeutic proteins |
| url | https://doi.org/10.1002/psp4.12465 |
| work_keys_str_mv | AT andrzejmkierzek aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT timothyphickling aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT isabelfigueroa aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT jcorykalvass aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT marjoleennijsen aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT krithikamohan aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT geertruidamveldman aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT akihiroyamada aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT hiroyukisayama aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT sachikoyokoo aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT abhishekgulati aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT renusdhanikula aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT jochemgokemeijer aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT tarekaleil aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT craigjthalhauser aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT mariogiorgi aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT maciejjswat aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT vijayalakshmichelliah aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT bengsmall aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT neilbenson aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT michaelwalker aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT kapilgadkar aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT valeriequarmby aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT rongdeng aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT andreaferrante aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT gemmaldickinson aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT janstefanvanderwalt aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT lianzhou aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT xiaoyingchen aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT hannahmjones aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT jatinnarula aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT sophietourdot aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT thierrylave aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT benjaminribba aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT piethvandergraaf aquantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT andrzejmkierzek quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT timothyphickling quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT isabelfigueroa quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT jcorykalvass quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT marjoleennijsen quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT krithikamohan quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT geertruidamveldman quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT akihiroyamada quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT hiroyukisayama quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT sachikoyokoo quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT abhishekgulati quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT renusdhanikula quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT jochemgokemeijer quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT tarekaleil quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT craigjthalhauser quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT mariogiorgi quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT maciejjswat quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT vijayalakshmichelliah quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT bengsmall quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT neilbenson quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT michaelwalker quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT kapilgadkar quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT valeriequarmby quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT rongdeng quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT andreaferrante quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT gemmaldickinson quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT janstefanvanderwalt quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT lianzhou quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT xiaoyingchen quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT hannahmjones quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT jatinnarula quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT sophietourdot quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT thierrylave quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT benjaminribba quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins AT piethvandergraaf quantitativesystemspharmacologyconsortiumapproachtomanagingimmunogenicityoftherapeuticproteins |